Barriers and facilitators to the administration of prehospital tranexamic acid: a paramedic interview study using the theoretical domains framework.
Emergency Medicine Journal · 2021-11-11 · Qualitative study
Abstract
BACKGROUND: Tranexamic acid (TXA) is an antifibrinolytic drug used to prevent bleeding. It was introduced as an intervention for post-traumatic haemorrhage across emergency medical services (EMS) in the UK during 2012. However, despite strong evidence of effectiveness, prehospital TXA administration rates are low. This study used the theoretical domains framework (TDF) to identify barriers and facilitators to the administration of TXA to trauma patients by EMS providers (paramedics) in the UK. METHODS: Interviews were completed with 18 UK paramedics from a single EMS provider organisation. A convenience sampling approach was used, and interviews continued until thematic saturation was reached. Semistructured telephone interviews explored paramedics' experiences of administering TXA to trauma patients, including identifying whether or not patients were at risk of bleeding. Data were analysed inductively using thematic analysis (stage 1). Themes were mapped to the theoretical domains of the TDF to identify behavioural theory-derived barriers and facilitators to the administration of TXA to trauma patients (stage 2). Belief statements were identified and assessed for importance according to prevalence, discordance and evidence base (stage 3). RESULTS: Barriers and facilitators to paramedics' administration of TXA to trauma patients were represented by 11 of the 14 domains of the TDF. Important barriers included a lack of knowledge and experience with TXA (Domain: Knowledge and Skills), confusion and restrictions relating to the guidelines for TXA administration (Domain: Social/professional role and identity), a lack of resources (Domain: Environmental context and resources) and difficulty in identifying patients at risk of bleeding (Domain: Memory, attention and decision processes). CONCLUSIONS: This study presents a behavioural theory-based approach to identifying barriers and facilitators to the prehospital administration of TXA to trauma patients in the UK. It identifies multiple influencing factors that may serve as a basis for developing an intervention to increase prehospital administration of TXA.
Abstract © the authors or publisher, via PubMed. Reuse and removal
Tags
Clinician perspective · Haemostatics · Implementation · Paramedics & EMTs · Tranexamic acid
Related articles
- Implementation of tranexamic acid for bleeding trauma patients: a longitudinal and cross-sectional study. (Emerg Med J, 2019)
- Tranexamic acid in trauma: A joint position statement and resource document of NAEMSP, ACEP, and ACS-COT. (J Trauma Acute Care Surg, 2025)
- Opportunities to expand delivery of prehospital tranexamic acid to bleeding trauma patients - findings from a prospective multicentre trauma study in the Western Cape Province, South Africa. (S Afr Med J, 2026)
- Tranexamic acid in polish pre-hospital emergency medicine and the competencies of medical rescue teams (Disaster and Emergency Medicine Journal, 2022)
- Validation of the BATT score for prehospital risk stratification of traumatic haemorrhagic death: usefulness for tranexamic acid treatment criteria. (Scand J Trauma Resusc Emerg Med, 2021)
- Assessing the clinical utilization of tranexamic acid by paramedics for patients with major trauma (ACUTE). (CJEM, 2021)